However, other studies conducted in mCRC patients treated with irinotecan in whom ABCB1 variants were analyzed did not show significant associations with severe neutropenia (De Mattia et al., 2013; Chen et al., 2015; Teft et al., 2015; Yan et al., 2016). This evidence concerns the gene ABCB1 and neutropenia.